top
Search terms
Results 1 - 6 of 6 - ordered by :
Eurointervention

Modi B.N., Koganti S., Jones D.A., Fung K., Rathod K.S., Akhtar M.M., Jain A., Knight C.J., Mathur A., Weerackody R., Wragg A. Aims: European guidelines state that with the exception of cardiogenic ...

Date : 21/05/2013 Item size : 32967 bytes
Eurointervention

EuroIntervention DES offer limited benefit over bare-metal stents inserted during vein graft PCI Abu-Own H., Guttman O., Jones D., Rathod K., Weerackody R., Jain A., Knight C., Mathur A., Wragg A. ...

Date : 15/05/2012 Item size : 32973 bytes
Eurointervention

EuroIntervention Prior coronary artery bypass graft patients treated with primary PCI have higher long-term adverse event rates Papalia F., De Silva H.N., Jones D.A., Rathod K.S., Guttmann O., ...

Date : 15/05/2012 Item size : 32555 bytes
Eurointervention

Bromage D., Jones D., Gallagher S., Akhtar M., Sammut E., Rathod K., Jain A., Knight C., Mathur A., Wragg A. Aims: Both mechanical thrombectomy and glycoprotein (GP) IIb/IIIa antagonists have been ...

Date : 15/05/2012 Item size : 33215 bytes
Eurointervention

The primary end-point was the first major adverse cardiac event (MACE) defined as death, non-fatal myocardial infarction, stroke or target vessel revascularisation. 1522 patients received abciximab ...

Date : 21/05/2013 Item size : 32602 bytes
Eurointervention

EuroIntervention DES offer limited benefit over bare metal stents inserted during vein graft PCI Akhtar M., Sammut E., McGill L., Jones D., Rathod K., Weerackody R., Jain A., Knight C., Mathur A., ...

Date : 17/05/2011 Item size : 34575 bytes